WHO ICTRP trial
Effects of semaglutide on gut microbiota during treatment in type 2 diabetes
ChiCTR2400094307 · Chinese Clinical Trial Registry (ChiCTR) · Recruiting
Key facts
| Trial ID | ChiCTR2400094307 |
|---|---|
| Public title | Effects of semaglutide on gut microbiota during treatment in type 2 diabetes |
| Scientific title | Effects of semaglutide on gut microbiota during treatment in type 2 diabetes |
| Primary sponsor | Huadong Hospital Affiliated to Fudan University |
| Registry | Chinese Clinical Trial Registry (ChiCTR) |
| Recruitment status | Recruiting |
| Study type | Observational study |
| Phase | 0 |
| Countries | China |
| Conditions | Type 2 diabetes |
| Interventions | GLP-1RA treatment group:none |
| Registration date | Dec 19, 2024 |
| Target size | GLP-1RA treatment group:60 |
| Registry page | chictr.org.cn |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: